Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organism

Digestive Diseases and Sciences

Volumn 49, Issue 6, 2004, Pages 925-930

  Winter, Trevor A ^a   Kidd, Mark ^a   Kaye, Philip ^a   Marks, I N ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

gastritis; growth factors; Helicobacter pylori; mucosal protein fractional synthesis

Indexed keywords

ANTIBIOTIC AGENT; CARBON 14; CLARITHROMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; LEUCINE; METRONIDAZOLE; SUCRALFATE; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; ERADICATION THERAPY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH MUCOSA;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHRONIC DISEASE; DUODENUM; FIBROBLAST GROWTH FACTORS; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEUCINE; RADIOACTIVE TRACERS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 3543040627     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000034550.08623.9b     Document Type: Article

References (40)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131, 1991
2. Wyatt JI, Rathbone BJ: Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl 142:44-49, 1988
3. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176, 1991
4. Hussell T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571-574, 1993
5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577, 1993
6. Cammarota G, Tursi A, Montalto M, Papa A, Branca G, Vecchio FM, Renzi C, Verzi A, Armuzzi A, Pretolani S, et al.: Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy. J Clin Gastroenterol 21:118-122, 1995
7. Zhang T, O'Keefe SJ, Winter T, Marks IN, Ogden J: Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans. Dig Dis Sci 43:2764-2770, 1998
8. Leung WK, To KF, Chan FK, Lee TL, Chung SC, Sung JJ: Interaction of Helicobacter pylori eradication and non-steroidal antiinflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis. Aliment Pharmacol Ther 14:879-885, 2000
9. Honig A, Witte F, Mirecka J, Binder C, Schauer A: Helicobacter pylori-induced hyperproliferation: relevance for gastric cancer development in connection with mutagenic factors. Anticancer Res 20:1641-1648, 2000
10. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, Dixon MF, Quirke P, Axon AT: Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 36:346-350, 1995
11. Lynch DA, Mapstone NP, Clarke AM, Jackson P, Moayyedi P, Dixon MF, Quirke P, Axon AT: Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J Clin Pathol 52:367-371, 1999
12. Safatle-Ribeiro AV, Ribeiro U, Jr., Clarke MR, Sakai P, Ishioka S, Garrido AB, Jr., Gama-Rodrigues J, Safatle NF, Reynolds JC: Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 44:243-252, 1999
13. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Shi TY: Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88:1870-1875, 1993
14. Tarnawski AS, Jones MK: The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27 (Suppl 1):S12-S20, 1998
15. Wong BC, Wang WP, So WH, Shin VY, Wong WM, Fung FM, Liu ES, Hiu WM, Lam SK, Cho CH: Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment Pharmacol Ther 15:1459-1465, 2001
16. Konturek PC, Ernst H, Konturek SJ, Bobrzynski AJ, Faller G, Klingler C, Hahn EG: Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 40:463-469, 1997
17. Konturek PC, Bobrzynski A, Konturek SJ, Bielanski W, Faller G, Kirchner T, Hahn EG: Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication. Scand J Gastroenterol 33:143-151, 1998
18. Schiemann U, Konturek J, Assert R, Rembiasz K, Domschke W, Konturek S, Pfeiffer A: mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication. Med Sci Monit 8:CR53-CR58, 2002
19. Schiemann U, Konturek JW, Osterhoff M, Assert R, Rembiasz K, Pfeiffer D, Schatz H, Domschke W, Pfeiffer A: Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa. Scand J Gastroenterol 36:23-31, 2001
20. Derynck R: Transforming growth factor-alpha. Mol Reprod Dev 27:3-9, 1990
21. Cutry AF, Kinniburgh AJ, Krabak MJ, Hui SW, Wenner CE: Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor alpha is calcium-independent. J Biol Chem 264:19700-51970, 1989
22. Konturek PC, Konturek SJ, Pierzchalski P, Bielanski W, Duda A, Marlicz K, Starzynska T, Hahn EG: Cancerogenesis in Helicobacter pylori infected stomach - Role of growth factors, apoptosis and cyclooxygenases. Med Sci Monit 7:1092-107, 2001
23. O'Keefe SJ: Measurement of gastric and duodenal mucosal protein turnover in humans. Dig Dis Sci 40:2465-2468, 1995
24. Bouteloup-Demange C, Boirie Y, Dechelotte P, Gachon P, Beaufrere B: Gut mucosal protein synthesis in fed and fasted humans. Am J Physiol 274:E541-E546, 1998
25. Watt PW, Lindsay Y, Scrimgeour CM, Chien PA, Gibson JN, Taylor DJ, Rennie MJ: Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: Use in studies of human tissue protein synthesis. Proc Natl Acad Sci USA 88:5892-5896, 1991
26. 13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31:1105-1112, 1982
27. Rennie MJ, Smith K, Watt PW: Measurement of human tissue protein synthesis: an optimal approach. Am J Physiol 266:E298-E307, 1994
28. Bennet WM, O'Keefe SJ, Haymond MW: Comparison of precursor pools with leucine, alpha-ketoisocaproate, and phenylalanine tracers used to measure splanchnic protein synthesis in man. Metabolism 42:691-695, 1993
29. Carbonnel F, Messing B, Darmaun D, Rimbert A, Rongier M, Rigal O, Koziet J, Thuillier F, Desjeux JF: Energy and protein metabolism in malnutrition due to nonneoplastic gastrointestinal diseases. Metabolism 44:1110-1115, 1995
30. O'Keefe SJ, Lemmer ER, Ogden JM, Winter T: The influence of intravenous infusions of glucose and amino acids on pancreatic enzyme and mucosal protein synthesis in human subjects. J Parent Enteral Nutr 22:253-258, 1998
31. Misiewicz JJ: The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol 6:207-208, 1991
32. Louw JA, Zak J, Lucke W, Le Roux E, Jaskiewicz K, Winter T, Lastovica A, Marks IN: Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol Suppl 191:28-31, 1992
33. Terano A, Shimada T, Hiraishi H: Sucralfate and Helicobacter pylori. J Gastroenterol 31 (Suppl 9):63-65, 1996
34. Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ: Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol Suppl 210:9-14, 1995
35. Szabo S, Kusstatscher S, Sandor Z, Sakoulas G: Molecular and cellular basis of ulcer healing. Scand J Gastroenterol Suppl 208:3-8, 1995
36. Patchett SE, Katelaris PH, Zhang ZW, Alstead EM, Domizio P, Farthing MJ: Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection. Gut 39:807-810, 1996
37. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 50:7415-7421, 1990
38. Moss SF, Calam J, Agarwal B, Wang S, Holt PR: Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38:498-501, 1996
39. Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C, Bleck JS, Manns MP: Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 113:1836-1847, 1997
40. Shibata J, Goto H, Arisawa T, Niwa Y, Hayakawa T, Nakayama A, Mori N: Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut 45:24-31, 1999